# Professor Aswath Damodaran discusses Valeant as an investment

1 Faculty News April 21, 2016 ![CNBC logo](/sites/default/files/styles/246w/public/assets/images/uat_027305.jpg?itok=Ipx0jiaQ)>

Excerpt from [CNBC](http://www.cnbc.com/2016/04/21/valuation-dean-valeant-is-a-buy.html) -- "'In every conceivable way this looks like a bad company, but at the right price, even a bad company could be a good investment,' he said in an interview with 'Closing Bell.' Valeant's problems include losing credibility with investors, delaying its financial filings and have a board of directors in 'flux,' \[[Damodaran](http://www.stern.nyu.edu/faculty/bio/aswath-damodaran)\] said."

[Read more](http://www.cnbc.com/2016/04/21/valuation-dean-valeant-is-a-buy.html)